RXDX
Prometheus Biosciences Inc
$199.92
Earnings Summary
Revenue | $1.11Mn |
Net Profits | $-40.88Mn |
Net Profit Margins | -3699.19% |
Highlights
Prometheus Biosciences Inc’s revenue fell -71.8% since last year same period to $1.11Mn in the Q1 2023. On a quarterly growth basis, Prometheus Biosciences Inc has generated 69.22% jump in its revenue since last 3-months.
Prometheus Biosciences Inc’s net profit fell -27.47% since last year same period to $-40.88Mn in the Q1 2023. On a quarterly growth basis, Prometheus Biosciences Inc has generated -5.45% fall in its net profits since last 3-months.
Prometheus Biosciences Inc’s net profit margin fell -352.1% since last year same period to -3699.19% in the Q1 2023. On a quarterly growth basis, Prometheus Biosciences Inc has generated 37.69% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Prometheus Biosciences Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.96 |
EPS Estimate Current Year | -0.96 |
Highlights
Prometheus Biosciences Inc’s earning per share (EPS) estimates for the current quarter stand at -0.96 - a -8.66% fall from last quarter’s estimates.
Prometheus Biosciences Inc’s earning per share (EPS) estimates for the current year stand at -0.96.
Key Ratios
Key ratios of the Prometheus Biosciences Inc post its Q2 2023 earnings
Earning Per Share (EPS) | 0 |
Highlights
Prometheus Biosciences Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q2 2023. This indicates that the Prometheus Biosciences Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-08-10 | -0.96 | 0 | 100% |
2023-05-09 | -0.88 | 0 | 100% |
₹0 US Stocks a/c Opening Fee